FDA deficiencies [GxP / QC / QA]

posted by Helmut Homepage – Vienna, Austria, 2018-06-20 15:45 (2127 d 01:36 ago) – Posting: # 18930
Views: 4,351

Dear all,

I suffered from a masochistic fit and explored the FDA’s Clinical Investigator Inspection List. Below the two main deficiencies.

[image]      Number of    Failure to follow     Inadequate and
Year  inspections  investigational plan  inaccurate records
2008      620          152 (24.5%)           92 (14.8%)
2009      587          150 (25.6%)           98 (16.7%)
2010      507          121 (23.9%)           84 (16.6%)
2011      381           91 (23.9%)           67 (17.6%)
2012      501          120 (24.0%)           76 (15.2%)
2013      423           96 (22.7%)           55 (13.0%)
2014      543          124 (22.8%)           78 (14.4%)
2015      582          159 (27.3%)           69 (11.9%)
2016      401           86 (21.4%)           37 ( 9.2%)
2017      269           43 (16.0%)           23 ( 8.6%)


Number of inspections and findings decreasing. Lean government?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
43 visitors (0 registered, 43 guests [including 5 identified bots]).
Forum time: 17:22 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5